Operating Margin

Despite currency woes and a tough market, the access solutions giant posts record sales and income, fueled by strategic acquisitions and innovation.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Canfor Pulp and Canfor Corp prepare for a critical joint earnings call on March 6 after a year of steep losses and severe market headwinds.

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.

One of America's oldest ethanol plants is betting big on a 'greenfield' tech overhaul, aiming to set a new standard for energy and carbon efficiency.

The world's largest jeweler misses 2025 growth targets and issues a sober 2026 forecast, prompting a major strategic shift to platinum-plated jewelry.

IUOE Local 150 backs Speaker Welch for State Central Committeeperson, signaling a major power play in Illinois Democratic politics post-Danny Davis.

DuPont launches a new reverse osmosis element promising dairy processors up to 50% higher productivity without changing their existing systems or practices.

The mobile competition giant is moving beyond tournaments, acquiring backend tools to create a one-stop shop for developers from creation to monetization.

The AI boom runs on powerful chips that generate immense heat. Discover how the once-overlooked HVAC industry is now a critical infrastructure investment.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

Digital asset firm Streamex appoints NYU's Anthony Marciano, signaling a strategic push for institutional credibility and M&A amid financial headwinds.

Global security leader Securitas acquires OSINT platform Liferaft, signaling a bold move to fuse digital threat intelligence with physical security services.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

The firm's assets grew on market gains, but significant client outflows and shrinking fees triggered a sharp stock drop, revealing key industry pressures.